Swiss drugmaker Roche has agreed to extend the takeover deadline in its $4.3 billion bid for U.S. gene therapy specialist Spark Therapeutics , adding it remains “fully committed” to the transaction and expects it to close this year.
Source:: Reuters – Business News
